Evaluation of Visual Acuity With a Reusable Toric Multifocal Contact Lens

Visual Acuity Clinical Trial

Official title:

Evaluation of Visual Acuity With a Reusable Toric Multifocal Contact Lens

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05000164
• Other study ID #: CR-6383
• Status: Completed
• Phase: N/A
• Start date: August 2, 2021
• Est. completion date: January 13, 2022

Study information

• Verified date: January 2023
• Source: Johnson & Johnson Vision Care, Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study is a bilateral, single-masked, single-arm, 4-visit dispensing study evaluating the visual performance of the study lenses.

Description:

The study is a bilateral, single-masked, single-arm, 4-visit dispensing study evaluating the visual performance of the study lenses.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: January 13, 2022
• Est. primary completion date: January 13, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria:

• Potential subjects must satisfy all of the following criteria to be enrolled in the

study:

1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.

2. Appear able and willing to adhere to the instructions set forth in this clinical protocol.

3. Be at least 40 and not more than 70 years of age at the time of screening.

4. Own a wearable pair of spectacles if required for their distance vision.

5. Be an adapted soft contact lens wearer in both eyes (i.e. has worn lenses a minimum of 2 days per week for at least 8 hours per wear day, for the past month).

6. Be an existing wearer of a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".

7. Have distance spherical component of refraction in the range of either -1.25 D to -3.75 D or +1.25 to +3.75 D in each eye.

8. Have refractive cylinder in the range of -0.75 D to -1.75 D in each eye, with their cylinder axis 90°±25°.

9. Have near ADD power requirement in the range of +0.75 D to +2.50 D in each eye.

10. Have best corrected distance visual acuity of 20/20-3 or better in each eye.

Exclusion Criteria:

• The subject must not:

1. Be currently pregnant or lactating.

2. Have any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.

3. Have any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens- Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).

4. Use systemic medications that may interfere with contact lens wear or cause blurred vision. See section 9.1 for additional details regarding excluded systemic medications.

5. Currently use ocular medication with the exception of rewetting drops.

6. Have any known hypersensitivity or allergic reaction to single use preservative free rewetting drops, sodium fluorescein, or Biotrue® multipurpose solution.

7. Have any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, cataract surgery, retinal surgery, etc.).

8. Have a history of amblyopia or strabismus.

9. Have a history of herpetic keratitis.

10. Have a history of irregular cornea.

11. Have a history of pathological dry eye.

12. Have participated in any contact lens or lens care product clinical trial within 14 days prior to study enrollment.

13. Be an employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).

14. Have clinically significant (Grade 2 or greater) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities or bulbar injection, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.

15. Have entropion, ectropion, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions.

16. Have any current ocular infection or inflammation.

17. Have any current ocular abnormality that may interfere with contact lens wear.

Related Conditions & MeSH terms

• Visual Acuity

Intervention

Device:
• Bausch + Lomb Ultra® Multifocal for Astigmatism
Study Lens

Locations

Country	Name	City	State
United States	The Eyecare Studio	Decatur	Georgia
United States	Vision Boutique	Houston	Texas
United States	Stam & Associates Eye Care	Jacksonville	Florida
United States	VRC-East	Jacksonville	Florida
United States	Vue Optical Boutique	Jacksonville	Florida
United States	Maitland Vision Center	Maitland	Florida
United States	Ctr For Opht and Vision Rsrch At Eye Associates Of New York	Manhattan	New York
United States	Botetourt Eyecare LLC	Salem	Virginia
United States	Sacco Eye Group	Vestal	New York

Sponsors (1)

Lead Sponsor	Collaborator
Johnson & Johnson Vision Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Binocular High Luminance High Contrast logMAR Visual Acuity	Binocular visual acuity was measured on a logMAR (Logarithm of Minimal Angle of Resolution) scale under high luminance high contrast condition. At distance (4 meters), VA is assessed using ETDRS (Early Treatment Diabetic Retinopathy Study) charts; while near (40 cm) and intermediate (64 cm) assessments were made using reduced Guillon-Poling charts. Letter-by-letter results calculated the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen visual acuity of 20/20.	4-Week Follow-up